Abbott MediaRoom http://abbott.mediaroom.com/ Abbott Declares 377th Consecutive Quarterly Dividend http://abbott.mediaroom.com/2018-02-16-Abbott-Declares-377th-Consecutive-Quarterly-Dividend Fri, 16 Feb 2018 11:20:00 -0500 http://abbott.mediaroom.com/2018-02-16-Abbott-Declares-377th-Consecutive-Quarterly-Dividend Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™ http://abbott.mediaroom.com/2018-02-07-Abbotts-App-for-FreeStyle-R-Libre-System-Now-Available-in-Europe-for-Both-iPhone-TM-and-Android-TM -- FREESTYLE LIBRELINK[1],[2] APP ENABLES FREESTYLE LIBRE USERS TO MONITOR THEIR GLUCOSE DIRECTLY WITH THEIR SMARTPHONE Wed, 07 Feb 2018 09:00:00 -0500 http://abbott.mediaroom.com/2018-02-07-Abbotts-App-for-FreeStyle-R-Libre-System-Now-Available-in-Europe-for-Both-iPhone-TM-and-Android-TM Abbott Reports Fourth-Quarter 2017 Results http://abbott.mediaroom.com/2018-01-24-Abbott-Reports-Fourth-Quarter-2017-Results - Fourth-quarter reported sales growth of 42.3 percent; comparable operational sales growth of 7.7 percent Wed, 24 Jan 2018 07:45:00 -0500 http://abbott.mediaroom.com/2018-01-24-Abbott-Reports-Fourth-Quarter-2017-Results Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients http://abbott.mediaroom.com/2018-01-04-Abbotts-Revolutionary-Continuous-Glucose-Monitoring-System-FreeStyle-R-Libre-Now-Available-To-Medicare-Patients - CMS reimbursement provides opportunity for Medicare patients who meet eligibility criteria to access FreeStyle Libre System Thu, 04 Jan 2018 09:00:00 -0500 http://abbott.mediaroom.com/2018-01-04-Abbotts-Revolutionary-Continuous-Glucose-Monitoring-System-FreeStyle-R-Libre-Now-Available-To-Medicare-Patients New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices http://abbott.mediaroom.com/2018-01-03-New-FDA-MR-Conditional-Labeling-Approvals-Further-Expand-Abbotts-Portfolio-of-MRI-Ready-Devices - New MR-conditional labeling for two of the company’s most widely-used high voltage devices continue cadence of MRI approvals within Abbott’s cardiac rhythm management portfolio Wed, 03 Jan 2018 09:00:00 -0500 http://abbott.mediaroom.com/2018-01-03-New-FDA-MR-Conditional-Labeling-Approvals-Further-Expand-Abbotts-Portfolio-of-MRI-Ready-Devices